U.S. markets close in 5 hours 53 minutes

  • S&P 500

    3,759.25
    -28.13 (-0.74%)
     

  • Dow 30

    30,366.31
    -237.05 (-0.77%)
     

  • Nasdaq

    13,221.02
    -116.14 (-0.87%)
     

  • Russell 2000

    2,107.63
    +1.03 (+0.05%)
     

  • Crude Oil

    53.03
    +0.69 (+1.32%)
     

  • Gold

    1,868.50
    +27.30 (+1.48%)
     

  • Silver

    27.42
    +1.50 (+5.78%)
     

  • EUR/USD

    1.2151
    +0.0027 (+0.22%)
     

  • 10-Yr Bond

    1.0880
    +0.0310 (+2.93%)
     

  • GBP/USD

    1.3723
    -0.0007 (-0.05%)
     

  • USD/JPY

    104.7460
    +0.5060 (+0.49%)
     

  • BTC-USD

    37,281.25
    +5,371.54 (+16.83%)
     

  • CMC Crypto 200

    738.01
    +70.38 (+10.54%)
     

  • FTSE 100

    6,415.34
    -110.81 (-1.70%)
     

  • Nikkei 225

    27,663.39
    -534.03 (-1.89%)
     

Global Cell Line Development Serum Market to 2027: Drug Development and Adoption of Novel Technologies for Cell Line Development Gaining Momentum

·4 min read

DUBLIN, Jan. 29, 2021 /PRNewswire/ -- The "Cell Line Development Serum Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; By Application; and Geography" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo
Research and Markets Logo

Fetal Bovine Serum Segment to Grow at Fast Pace during 2020-2027.

The market is expected to reach US$ 1,467.92 million by 2027 from US$ 915.58 million in 2019; it is estimated to grow at a CAGR of 6.1% from 2020 to 2027.

The report provides trends prevailing in the global cell line development serum market, and the drivers and hindrances pertaining to the market growth.

Based on type, the global cell line development serum market is segmented into fetal bovine serum, adult bovine serum, porcine serum, horse serum, other animal serum. Fetal bovine serum segment held the largest share of the market in 2019 and is expected to register the highest CAGR of the market during the forecast period. Fetal bovine serum (FBS) derived from the blood drawn from a bovine fetus through a closed collection system from the slaughterhouse. FBS is the most widely used serum-supplement for the in vitro cell culture of eukaryotic cells. This is because it has a deficient level of antibodies and contains more growth factors, allowing for versatility in different cell culture applications.

Increasing adoption of regenerative medicines and rising R& D investments and collaborations among by pharmaceutical and biotechnology companies treatments are the key factors driving the growth of the cell line development serum market. Moreover, increasing vaccine production is likely to have positive impact on the market in the coming years. However, risk of contamination, misidentification, and random alternations in cell lines are restricting the market growth.

Lonza, Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation (MERCK KGaA), Cytiva (Danaher), PAN Biotech, Corning Incorporated, European Collection of Cell Cultures (ECACC), Bovogen Biologicals Pty Ltd., WuXi AppTec, and American Type Culture Collection (ATCC) are among the leading companies operating in the cell line development serum market.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation

2. Cell Line Development Serum Market - Key Takeaways

3. Research Methodology

4. Cell Line Development Serum - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion

5. Cell Line Development Serum Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Regenerative Medicines
5.1.2 Rising R&D Investments and Collaborations among by Pharmaceutical and Biotechnology Companies
5.2 Key Restraints
5.2.1 Risk of Contamination, Misidentification, and Random Alternations in Cell Lines
5.3 Key Opportunities
5.3.1 Increasing Vaccine Production
5.4 Future Trends
5.4.1 Drug Development and Adoption of Novel Technologies for Cell Line Development
5.5 Impact Analysis

6. Cell Line Development Serum Market - Global Analysis
6.1 Global Cell Line Development Serum Market Revenue Forecast and Analysis
6.2 Global Cell Line Development Serum Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Cell Line Development Serum Market - Revenue and Forecasts to 2027 - Type
7.1 Overview
7.2 Global Cell Line Development Serum Market, by Type, 2019 & 2027 (% Share)
7.3 Fetal Bovine Serum
7.4 Adult Bovine Serum
7.5 Porcine Serum
7.6 Horse Serum

8. Cell Line Development Serum Market Analysis and Forecasts to 2027 - Application
8.1 Overview
8.2 Global Cell Line Development Serum Market Share by Application 2019 & 2027 (%)
8.3 Drug Discovery
8.4 Bioproduction
8.5 Tissue Engineering and Regenerative Medicines
8.6 Toxicity Testing
8.7 Academic Research

9. Cell Line Development Serum Market Revenue and Forecast to 2027 - Geographical Analysis
9.1 North America Cell Line Development Serum Market, Revenue and Forecast to 2027

10. Impact Of COVID-19 Pandemic on Global Cell Line Development Serum Market

11. Cell Line Development Serum Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview

12. Company Profiles

  • Lonza

  • Thermo Fisher Scientific Inc.,

  • Sigma-Aldrich Corporation (MERCK KGaA)

  • Cytiva (Danaher)

  • PAN Biotech

  • Corning Incorporated

  • European Collection of Cell Cultures (ECACC)

  • Bovogen Biologicals Pty Ltd.

  • WuXi AppTec

  • American Type

For more information about this report visit https://www.researchandmarkets.com/r/5qwz87

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/global-cell-line-development-serum-market-to-2027-drug-development-and-adoption-of-novel-technologies-for-cell-line-development-gaining-momentum-301217981.html

SOURCE Research and Markets

Latest Stories

  • The somewhat boring reason it appears that Robinhood yanked trading on some securities

    After enduring a day's worth of taking a beating across social media, government, and the various app stores of the mobile world, Robinhood took to its own blog and CEO's Twitter account to explain why it had halted trading of some stocks earlier today. Speculation that Robinhood was limiting the trading ability of those users at the behest of, pick your poison, Citadel, the US government, hedge funds, Janet Yellen, or others, ran rampant.

  • Who’s the next GameStop? These are the 10 most shorted stocks

    Short selling is a trading strategy based on speculation that a company’s stock will drop in price. GameStop, a struggling mall-based retailer of video games, has been an attractive target for short sellers, but the stock has been rallying point for retail investors on Reddit, and its share prices have shot up as the short investors have been squeezed. After the closing bell today, GameStop’s market value was $13.5 billion or about the same value as the New York Giants, the Dallas Cowboys, and the New England Patriots, the three most valuable National Football League teams, combined.

  • Biogen Stock Pops After FDA Extends Review For Key Alzheimer's Drug

    Biogen stock popped Friday after the Food and Drug Administration extended the review period for its key Alzheimer's treatment by three months.

  • What minimum wage increases did to McDonald’s restaurants — and their employees

    A Princeton economist looked at the impacts of wage increases over five years at U.S. McDonald's fast-food restaurants.

  • Bitcoin Investors May Lose Everything, Central Banker Warns

    (Bloomberg) -- Bitcoin investors need to be prepared to “lose all their money,” European Central Bank governing council member Gabriel Makhlouf said, the latest warning from a central banker on the cryptocurrency.“Personally, I’m not sure why people invest in those sorts of assets, but they see them as assets clearly,” Makhlouf, who is also governor of Ireland’s central bank, told Bloomberg TV on Friday. “Our role is to make sure that consumers are protected.”Makhlouf’s comments echo skepticism from ECB leaders. The cryptocurrency is a “highly speculative asset,” President Christine Lagarde said this month. Bitcoin prices have more than doubled since November and topped $40,000 earlier this month. Large movements in its value are common, with four daily swings of more than 5% in the past nine days.On Friday, Bitcoin rallied above $35,000, with brokers attributing the move to Elon Musk mentioning the cryptocurrency in his bio page on Twitter.Bitcoin Jumps Above $35,000 as Musk Puts It Into Twitter ProfileStill, Makhlouf doesn’t see “financial stability issues at the moment arising from Bitcoin itself.”“I worry more about about consumers making the right choices,” he said.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Dow Jones Futures Tumble On J&J Vaccine News; GME Stock, Apple Chipmaker, Novavax Soar

    Futures are selling off on J&J coronavirus vaccine news, but GME stock and AMC surged. A Novavax vaccine is highly effective.

  • Elon Musk-Prompted Bitcoin Price Surge Causes Liquidation of $387M in Shorts

    The shorts were liquidated after Elon Musk added "Bitcoin" to his Twitter bio and prices rose by over 15%.

  • 'I vividly remember': Redditors cheering on market mayhem recall growing up amid the Great Recession

    Scroll through the comments on the WallStreetBets forum and you’ll find stories of financial struggles growing up during the great recession.

  • Get ready for a 10% stock drop, driven by the 3 ‘Rs,’ warns Bank of America

    Bank of America was ringing alarm bells over equities on Friday, as it warned a correction is looming. “3R’s of rates, regulation, redistribution are the historic catalysts that end bull markets & bubbles…we say all ’21 events, not ’22, and all spell lower/volatile coming quarters/years,” said Michael Hartnett, chief investment strategist at the bank, in the Flow Show note to clients. On the regulation side, Hartnett said investors should take note of China’s central bank tightening up liquidity this week.

  • Silver Is the Latest Market Hit by Reddit Day-Trader Frenzy

    (Bloomberg) -- The first signs that the silver market was about to get hit came Wednesday.Comments began appearing on the Reddit chatroom r/wallstreetbets -- the investor board now famous for fueling an astonishing short squeeze in Gamestop Corp. that sent its market value soaring by 788% in a week. Posters started egging each other on to pile into IShares Silver Trust, the largest silver exchange-traded fund around, saying banks have been manipulating silver prices, keeping them artificially low and masking a shortfall in physical supplies. One post described it as “THE BIGGEST SHORT SQUEEZE IN THE WORLD.”If this sounds all too familiar, it’s because it has been the rallying cry of conspiracy theorists in precious metals circles for decades, if not centuries. With their constant railing against banks and big government colluding to mask inflation, it was only a matter of time before they and retail investors raging against the financial machine joined forces.To say there was a strategy may be overstating things, but the impact was felt across the markets.Small silver miners began surging first thing in the New York morning Thursday with First Majestic Silver Corp., cited on Reddit as a short-squeeze target, soaring as much as 39%. Then retail investors started flooding into IShares Silver Trust, driving it up by as much as 7.2%. Spot silver gained 6.8% at one point, the biggest jump since August.“There’s a short squeeze going on in silver. The ‘hoodies are all rolling into silver and the party is on,” Phil Streible, chief market strategist at Blue Line Futures LLC in Chicago, said in a phone call. “All those other stocks like GameStop and AMC, they’re dumping because they’ve been restricted, and they gotta go into other short opportunities and silver is an easy identifiable target.”The economic data that came out Thursday morning, which included a larger-than-expected drop in jobless claims, have become “a moot point” for traders, Bob Haberkorn, senior market strategist at RJO Futures said by phone. “This isn’t predicated on any global events, it’s just people on a message board putting all their guns towards the precious metals markets.”Options markets were bid up in the frenzy, with traders and brokers seeing wide bid/ask spreads on the IShares and Comex contracts. A record 3.1 million IShares Silver Trust options contracts traded.“The implied volatility being quoted in the options market at this moment is wider than I’ve ever witnessed.” James Gavilan, principal and adviser at Gavilan Commodities LLC, said in a phone interview. “The market is factoring in large swings in the silver price, and an already illiquid market is showing extremely wide quotes for options, which means that traders are concerned about the difficulty of hedging their positions.”To see such wide volatility spreads is “mind boggling, breath taking, it’s shocking really,” said Gavilan.The buying in silver and gold spilled over to the base metals complex on the London Metal Exchange, with copper erasing early losses, while “Chinese night desks buying” also helped the metal, according to Tai Wong, head of metals derivatives trading at BMO Capital Markets. Copper for three-month delivery rose 0.6% to $7,873 a ton in London.(Updates with record options volume in the eighth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • The GameStop saga finds its villain: Morning Brief

    Top news and what to watch in the markets on Friday, January 29, 2021.

  • Tiny Driller Skyrockets 959% After Reddit Craze Spreads to Oil

    (Bloomberg) -- An obscure company that employs five people and appears to produce negligible amounts of oil and natural gas from some wells in Appalachia became the latest Reddit-fueled day-trading craze, soaring nearly 1,000% to become a $128 million company in a matter of hours.New Concept Energy Inc. got a mention by retail traders on the WallStreetBets forum on Reddit on a day when brokerages including Robinhood Markets clamped down on trading in shares such as GameStop Corp. after some of the wildest stock swings the markets have seen in recent years.For a company that produces a mere 70 barrels of oil equivalent a day and has a board whose average age is 74, that was still enough to send its shares up by a whopping 959% to $25, the highest since 2000.Short interest in New Concept Energy has fallen to 0.3% of its float from 13% earlier this month, according to data from S3 Partners.The company didn’t immediately respond to a request for a comment on Thursday’s meteroric stock performance.At the end of 2019, New Concept Energy had 153 producing gas wells and 44 non-producing wells, with mineral leases across 20,000 acres, according to regulatory filings.The company lost 46 cents a share on revenue of $590,000 in 2019, according to its annual report.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Robinhood raises $1B after trading halts to keep its platform running

    After a turbulent week for the stock market and halts to the trading of certain speculative securities including GameStop (GME) and AMC, consumer investing app Robinhood has raised new capital. The new funds total more than $1 billion, with the company telling TechCrunch that they were raised from its existing investor base. The New York Times reports that the company raised the new equity capital after tapping its credit lines for $500 to $600 million; the company did not answer a question from TechCrunch regarding its credit lines.

  • GameStop: Meet the amateur traders fighting Wall Street

    They're young, they're financially savvy and they're angry at being shut out of GameStop share trading.

  • Will the SEC sue GameStop traders? The case could pose a 'super weird' challenge

    Traders who gobbled up GameStop stock to squeeze short sellers could end up on the defending side of enforcement action.

  • Chevron Posts Surprise Loss As Revenue Also Misses

    Chevron unexpectedly reported to a fourth-quarter loss Friday despite the rebound in crude oil prices, in the first report from a global oil major.

  • Silver rallies after Reddit post about executing a ‘short squeeze’

    Silver futures rally on Thursday, heading for their highest finish in three weeks, following a post by a Reddit user who suggested executing a "short squeeze" on silver.

  • Time to Turn Bullish on These 2 Oil Stocks, Says Raymond James

    We are entering a new paradigm for the oil and gas industry, one far removed from the Trump Presidency’s pro-drilling policies. The Biden Admin is likely to cut back on oil and gas production in the US, in favor of promoting renewable energy sources and carbon pollution reduction. In the short run, his policies are likely to push oil and gas prices up – and that may turn out to help the hydrocarbon sector, at least at the bottom line, over the coming year. But for the oil companies, the lessons of 2020 appear in the balance sheets. The massive spike down in prices last May, followed by a quick recovery, only to finish the year at roughly the same price as it began – all of this has the producers looking to cut back on spending, consolidate or reduce debt, and maintain free cash flow. In the words of Raymond James’ oil industry analyst John Freeman: “[We] enter 4Q20 earnings and 2021 capital budget season with WTI trading, ironically, in essentially the same low $50s range as we did this time last year. While crude is largely in the same spot, the industry has definitely undergone a strategic shift with balance sheet health and returning capital to shareholders by far the highest priorities.” In addition to noting the general trend of the industry after a difficult year, Freeman has also been updating his stance on individual oil and gas stocks. Two in particular have gotten Freeman’s attention. He sees at least 50% upside potential for each of them. We ran the two through TipRanks' database to see what other Wall Street's analysts have to say about them. Apache Corporation (APA) With headquarters in Houston, Texas, Apache is an important operator in the North American oil industry. The company’s US hydrocarbon exploration and production activities are located in the Permian Basin, along the Gulf Coast, and in the Gulf Mexico. Apache also has operations in the UK (in the North Sea), in Egypt (in the Western Desert), and in Suriname (offshore). The company’s Permian holdings include 665.8 million barrels of oil equivalent, 66% of its proven reserves. The company beat the quarterly revenue expectations in the third quarter, with $1.12 billion at the top line. Since reporting the Q3 revenue, Apache’s stock has gained 71%. The company reported 445,000 barrels of oil equivalent per day in Q3 production. Covering the stock for Raymond James, analyst John Freeman writes: “We continue to like Apache's diversified portfolio of U.S. onshore and international assets (Egypt, the North Sea, and Suriname), and given Apache's considerable commodity exposure (only hedged Waha basis in 2021), the company is ideally situated to capitalize on our projected resurgence in commodity prices in the 2021/2022 timeframe. Adding to this, the operator has an extremely robust FCF profile [and] proven commitment to capital discipline…” In line with these comments, the analyst gives APA a Strong Buy rating and a $24 price target that implies a 60% upside potential over the coming 12 months. (To watch Freeman’s track record, click here) Freeman leads the Bulls on Apache. The stock has a Moderate Buy from the analyst consensus, based on 12 reviews that include 6 Buys, 5 Holds, and 1 Sell. The shares are selling for $14.94, and their $19.30 average price target suggests room for 29% upside growth this year. (See APA stock analysis on TipRanks) Diamondback Energy (FANG) Also based in Texas, Diamondback Energy is another player in the Permian Basin energy boom. The company boasts an $8.9 billion market cap and saw revenues hit $720 million in the third quarter of 2020. Production in the quarter averaged 287.8 thousand barrels of oil equivalent per day. Diamondback’s reserves total more than 1.12 billion barrels of oil equivalent, of which 63% are oil and 37% are natural gas and related liquids. Diamondback is expanding its operations through M&A activity. In December of last year, the company announced that it will be acquiring QEP Resources, a natural gas driller in the Midland Basin of the Permian formation along with operations in North Dakota’s Williston formation. The acquisition is an all-stock deal, worth an estimated $2.2 billion. QEP brings 49,000 acres in the Midland for potential development, an average production of 48,300 thousand BOE per day, and 48 ‘drilled but uncompleted’ wells. These assets are accretive to Diamondback’s portfolio. In a related piece of news, Diamondback has announced that it will also be acquiring Guidon, another rival Texas oil producer. Guidon brings additional Permian assets to Diamondback, and the acquisition is significant, valued at $862 million in both cash and stock. Casting his eye on Diamondback, Freeman sees the company in a strong position to meet the challenges of both the energy environment and the Biden Administration’s regulatory policies. “Going forward with the addition of QEP and Guidon acreage we anticipate the Midland accounts for ~75% of pro forma activity. Note that even after the QEP/Guidon acquisitions, FANG still has no federal acreage exposure - a significant positive given regulatory uncertainty will likely persist following the expiration of the 60-day leasing moratorium… We believe FANG offers considerable upside potential over the long-term and are confident in the company's ability to weather near-term commodity uncertainties,” Freeman opined. Unsurprisingly, Freeman rates FANG as a Strong Buy, along with a $91 price target. This figure indicates confidence in ~51% growth over the next 12 months. (To watch Freeman’s track record, click here) There’s broad agreement on Wall Street with Freeman’s position here. FANG stock holds a Strong Buy rating from the analyst consensus, based on 13 recent Buy reviews against just 3 Holds. The average price target is $67.37, which implies ~12% upside from the current trading price of $67.37. (See FANG stock analysis on TipRanks) To find good ideas for oil stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

  • Ericsson tops forecasts as 5G lifts off

    Ericsson beat fourth-quarter core earnings forecasts on Friday, helped by strong sales of 5G equipment and the ban on Chinese rival Huawei in several countries. Not only is Ericsson is selling more, but it is also earning more from each sale, with gross margins rising to 40.6% in the quarter from 36.8% a year earlier. In particular, the core Networks business saw margins at 43.5% from 41.1% a year earlier, on a 20% rise in sales.

  • Stock market news live updates: Stocks fall, looking to end the week lower

    Stocks dipped Friday morning, reversing course after a recovery rally on Thursday.